NZ710361A - Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1h)-one derivatives having both β2 adrenergic receptor agonist and m3 muscarinic receptor antagonist activities - Google Patents
Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1h)-one derivatives having both β2 adrenergic receptor agonist and m3 muscarinic receptor antagonist activitiesInfo
- Publication number
- NZ710361A NZ710361A NZ710361A NZ71036114A NZ710361A NZ 710361 A NZ710361 A NZ 710361A NZ 710361 A NZ710361 A NZ 710361A NZ 71036114 A NZ71036114 A NZ 71036114A NZ 710361 A NZ710361 A NZ 710361A
- Authority
- NZ
- New Zealand
- Prior art keywords
- hydroxyquinolin
- derivatives
- salts
- hydroxyethyl
- amino
- Prior art date
Links
- 102100039705 Beta-2 adrenergic receptor Human genes 0.000 title abstract 2
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 title abstract 2
- 239000000048 adrenergic agonist Substances 0.000 title abstract 2
- 229940126157 adrenergic receptor agonist Drugs 0.000 title abstract 2
- 108010014499 beta-2 Adrenergic Receptors Proteins 0.000 title abstract 2
- 230000000694 effects Effects 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- JKMZVSFWKKXBGL-UHFFFAOYSA-N NCC(O)N1C(C=CC2=CC=CC(=C12)O)=O Chemical class NCC(O)N1C(C=CC2=CC=CC(=C12)O)=O JKMZVSFWKKXBGL-UHFFFAOYSA-N 0.000 title 1
- 239000003149 muscarinic antagonist Substances 0.000 title 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 abstract 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 abstract 1
- 230000009977 dual effect Effects 0.000 abstract 1
- ZXZKYYHTWHJHFT-UHFFFAOYSA-N quinoline-2,8-diol Chemical class C1=CC(=O)NC2=C1C=CC=C2O ZXZKYYHTWHJHFT-UHFFFAOYSA-N 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention is directed to crystalline addition salts of (i) 8-hydroxyquinolin-2(1H)-one derivatives of formula (I) and (ii) a hydroxycarboxylic acid, a sulfonic acid or a sulfimide, or a pharmaceutically acceptable solvates thereof with activity as dual β2 adrenergic receptor agonists and M3 muscarinic receptor antagonists.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13382060 | 2013-02-27 | ||
| US201361804558P | 2013-03-22 | 2013-03-22 | |
| PCT/EP2014/053871 WO2014131851A1 (en) | 2013-02-27 | 2014-02-27 | SALTS OF 2-AMINO-1-HYDROXYETHYL-8-HYDROXYQUINOLIN-2(1H)-ONE DERIVATIVES HAVING BOTH β2 ADRENERGIC RECEPTOR AGONIST AND M3 MUSCARINIC RECEPTOR ANTAGONIST ACTIVITIES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ710361A true NZ710361A (en) | 2020-05-29 |
Family
ID=67180452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ710361A NZ710361A (en) | 2013-02-27 | 2014-02-27 | Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1h)-one derivatives having both β2 adrenergic receptor agonist and m3 muscarinic receptor antagonist activities |
Country Status (4)
| Country | Link |
|---|---|
| CY (1) | CY1120279T1 (en) |
| NI (1) | NI201500107A (en) |
| NZ (1) | NZ710361A (en) |
| SV (1) | SV2015005045A (en) |
-
2014
- 2014-02-27 NZ NZ710361A patent/NZ710361A/en not_active IP Right Cessation
-
2015
- 2015-08-14 NI NI201500107A patent/NI201500107A/en unknown
- 2015-08-26 SV SV2015005045A patent/SV2015005045A/en unknown
-
2018
- 2018-05-25 CY CY20181100566T patent/CY1120279T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NI201500107A (en) | 2017-03-13 |
| CY1120279T1 (en) | 2019-07-10 |
| SV2015005045A (en) | 2018-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12015501754A1 (en) | Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1h)-one derivatives having both �2 adrenergic receptor agonist and m3 muscarinic receptor antagonist activities | |
| PH12016500125A1 (en) | Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1h)-one derivatives having both muscarinic receptor antagonist and �2 adrenergic receptor agonist activities | |
| MY169479A (en) | Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity | |
| UA111640C2 (en) | DERIVATIVES [1,2,3] TRIAZOLO [4,5-d] PYRIMIDINE AS A cannabinoid receptor agonist 2 | |
| MA40170A (en) | Heterocyclic morphinan derivatives and use thereof | |
| MX350419B (en) | (THIENO[2,3-b][1,5]BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS. | |
| EA201370149A1 (en) | ANTAGONISTS RECEPTOR | |
| MX360699B (en) | Piperazine substituted bridged spiro[2.4]heptane derivatives as alx receptor agonists. | |
| MX2015017541A (en) | Difluoroethyl-oxazole substituted bridged spiro[2.4]heptane derivatives as alx receptor agonists. | |
| EA201391706A1 (en) | COMPOUNDS (THIENO [2,3-B] [1,5] BENZOXAZEPIN-4-IL) PIPERAZIN-1-ILA AS COMPOUNDS WITH DOUBLE ACTIVITY OF REVERSE AGONISTS H1 / Antagonists 5-HT | |
| NZ710361A (en) | Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1h)-one derivatives having both β2 adrenergic receptor agonist and m3 muscarinic receptor antagonist activities | |
| EA201390966A1 (en) | SUBSTITUTED COMPOUNDS [(5H-PIRROLO [2,1-C] [1,4] BENZODIAZEPIN-11-IL) PIPERAZIN-1-IL] -2,2-DIMETHYL-PROPANE ACID AS REVERSE AGONISTS HI TURNSTRATURAL HYDRAHYLINUM ACID | |
| EA201591099A1 (en) | TIENO ([2,3-b] [1,5] BENZOXASEPIN-4-IL) PIPERAZIN-1-ILY COMPOUNDS AS AGENTS WITH DOUBLE ACTIVITY: REVERSE H1 / ANTAGONIST 5-HT AGONISTS | |
| TH163971A (en) | Derivative salt 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2- (1H) -transfer (2-amino-1-hydroxyethyl-8-hydroxyquinolin-2 (1H) -one) which has both muscarinic activity Antagonist and active receptor (beta) 2 adrenergic receptor agonist |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 27 FEB 2022 BY COMPUTER PACKAGES INC Effective date: 20210130 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 27 FEB 2023 BY COMPUTER PACKAGES INC Effective date: 20220130 |
|
| LAPS | Patent lapsed |